These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 14088966
1. COLORIMETRIC METHOD FOR DETERMINATION OF URACIL MUSTARD AND RELATED ALKYLATING AGENTS. PETERING HG, VANGIESSEN GJ. J Pharm Sci; 1963 Dec; 52():1159-62. PubMed ID: 14088966 [No Abstract] [Full Text] [Related]
2. CYTOTOXIC ACTIVITY COMPARED WITH PHOTOMETRIC MEASUREMENTS OF SELECTED ALKYLATING AGENTS. SANDERSON RP, MCKENNA JM, BLAKEMORE WS. Nature; 1965 Jan 30; 205():479-81. PubMed ID: 14265292 [No Abstract] [Full Text] [Related]
3. COUPLING OF CYCLIC CHEMOTHERAPEUTIC COMPOUNDS TO IMMUNE GAMMA-GLOBULINS. DECARVALHO S, RAND HJ, LEWIS A. Nature; 1964 Apr 18; 202():255-8. PubMed ID: 14167779 [No Abstract] [Full Text] [Related]
4. A comparative study with three alkylating agents: mechlorethamine, cyclophosphamide, and uracil mustard. GOLD GL, SALVIN LG, SHNIDER BI. Cancer Chemother Rep; 1962 Feb 18; 16():417-9. PubMed ID: 13899670 [No Abstract] [Full Text] [Related]
6. Antibody-Drug Conjugates (ADCs): Magic Bullets at Last! Lambert JM. Mol Pharm; 2015 Jun 01; 12(6):1701-2. PubMed ID: 26027696 [No Abstract] [Full Text] [Related]
7. EFFECT OF TESTOSTERONE ENANTHATE AND ALKYLATING AGENTS ON MULTIPLE MYELOMA. BRODSKY I, DENNIS LH, DECASTRO NA, BRADY L, KAHN SB. JAMA; 1965 Sep 13; 193():874-8. PubMed ID: 14341128 [No Abstract] [Full Text] [Related]
8. [EXPERIMENTAL AND CLINICAL FINDINGS ON THE THERAPEUTIC USE OF A NEW ALKYLATING DRUG: URACIL MUSTARD]. BALLERINI G, CASTOLDI G, RICCI N, TENZE L. Clin Ter; 1965 Jan 15; 32():49-61. PubMed ID: 14262587 [No Abstract] [Full Text] [Related]
9. ALKYLATING AGENTS DERIVED FROM INDOLES. IV. SYNTHESIS OF THE 5-NITROGEN MUSTARD OF INDOLE-3-CARBOXYLIC ACID. DEGRAW J, GOODMAN L. J Med Chem; 1964 Mar 15; 7():213-5. PubMed ID: 14187378 [No Abstract] [Full Text] [Related]
10. NITROGEN MUSTARDS DERIVED FROM 3,4-DIHYDRO-2, 4-DIOXO-1(2H)-PYRIMIDINEPROPIONIC AND -BUTYRIC ACIDS. MARTINEZ AP, LEE WW, GOODMAN L. J Med Chem; 1965 Mar 15; 8():187-9. PubMed ID: 14332657 [No Abstract] [Full Text] [Related]
11. CLINICAL EVALUATION OF URACIL MUSTARD. WILLIAMS HM. Cancer Chemother Rep; 1963 Oct 15; 32():73-6. PubMed ID: 14088838 [No Abstract] [Full Text] [Related]
12. URACIL MUSTARD: A POTENT INDUCER OF LUNG TUMORS IN MICE. ABELL CW, FALK HL, SHIMKIN MB, WEISBURGER EK, WEISBURGER JH, GUBAREFF N. Science; 1965 Mar 19; 147(3664):1443-5. PubMed ID: 14268720 [Abstract] [Full Text] [Related]
13. [EXPERIMENTAL STUDIES ON CARCINOMA AND ITS ARRESTED STATE. 9. PHARMACOLOGY OF URACIL MUSTARD, A CHEMOTHERAPEUTIC ANTINEOPLASTIC AGENT]. CHANG M. Nihon Yakurigaku Zasshi; 1964 Sep 20; 60():413-34. PubMed ID: 14271233 [No Abstract] [Full Text] [Related]
14. A STUDY OF COMPARATIVE CHEMICAL AND BIOLOGICAL ACTIVITIES OF ALKYLATING AGENTS. BARDOS TJ, DATTA-GUPTA N, HEBBORN P, TRIGGLE DJ. J Med Chem; 1965 Mar 20; 8():167-74. PubMed ID: 14335145 [No Abstract] [Full Text] [Related]
15. STUDIES OF THE MODE OF ACTION OF TUMOUR-GROWTH-INHIBITING ALKYLATING AGENTS. IV. IN-VITRO REACTIONS OF 2-CHLOROETHYLARYLAMINES. ROBERTS JJ, WARWICK GP. Biochem Pharmacol; 1963 Dec 20; 12():1315-9. PubMed ID: 14096418 [No Abstract] [Full Text] [Related]
16. DENTAL LESIONS IN RAT INDUCED BY RADIOMIMETIC AGENTS. HEBBORN P, MISHRA LC, DALTON C, WILLIAMS JP. Arch Pathol; 1965 Aug 20; 80():110-5. PubMed ID: 14326433 [No Abstract] [Full Text] [Related]
17. [EFFECT OF SOME ANTINEOPLASTIC AGENTS ON LIVER FUNCTION IN THE MOUSE]. SYRKII AB, MIKHAILOVA AM. Klin Lech Zlokach Novoobraz; 1963 Aug 20; 92():135-8. PubMed ID: 14182288 [No Abstract] [Full Text] [Related]
19. [EXPERIMENTAL CHROMOSOME ALTERATIONS DUE TO CYCLOPHOSPHAMIDE AND URACIL-MUSTARD]. BALLERINI G, BOSI L, PARESCHI PL, PUNTURIERI E. Arcisp S Anna Ferrara; 1964 Aug 20; 17():1139-52. PubMed ID: 14265725 [No Abstract] [Full Text] [Related]